BNTX logo

BioNTech SE (BNTX) Operating profit

annual operating profit:

-$695.96M-$1.68B(-171.08%)
December 31, 2024

Summary

  • As of today (August 18, 2025), BNTX annual operating income is -$695.96 million, with the most recent change of -$1.68 billion (-171.08%) on December 31, 2024.
  • During the last 3 years, BNTX annual operating profit has fallen by -$21.54 billion (-103.34%).
  • BNTX annual operating profit is now -103.34% below its all-time high of $20.84 billion, reached on December 31, 2021.

Performance

BNTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

quarterly operating profit:

-$542.60M+$19.40M(+3.45%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX quarterly operating income is -$542.60 million, with the most recent change of +$19.40 million (+3.45%) on June 30, 2025.
  • Over the past year, BNTX quarterly operating profit has increased by +$204.13 million (+27.34%).
  • BNTX quarterly operating profit is now -110.10% below its all-time high of $5.37 billion, reached on September 30, 2021.

Performance

BNTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM operating profit:

-$168.65M+$204.13M(+54.76%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX TTM operating income is -$168.65 million, with the most recent change of +$204.13 million (+54.76%) on June 30, 2025.
  • Over the past year, BNTX TTM operating profit has increased by +$252.49 million (+59.95%).
  • BNTX TTM operating profit is now -100.80% below its all-time high of $20.97 billion, reached on March 31, 2022.

Performance

BNTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

BNTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-171.1%+27.3%+60.0%
3 y3 years-103.3%-126.5%-100.9%
5 y5 years-238.8%-509.0%+33.6%

BNTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-103.3%at low-115.3%+27.3%-100.9%+65.5%
5 y5-year-103.3%at low-110.1%+27.3%-100.8%+65.5%
alltimeall time-103.3%at low-110.1%+27.3%-100.8%+65.5%

BNTX Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$542.60M(-3.5%)
-$168.65M(-54.8%)
Mar 2025
-
-$562.00M(-160.8%)
-$372.78M(+3.1%)
Dec 2024
-$695.96M(-171.1%)
$924.39M(+7904.8%)
-$361.70M(-26.1%)
Sep 2024
-
$11.55M(-101.5%)
-$489.18M(+16.2%)
Jun 2024
-
-$746.73M(+35.5%)
-$421.14M(+45.9%)
Mar 2024
-
-$550.92M(-169.1%)
-$288.66M(-129.9%)
Dec 2023
$979.17M(-93.9%)
$796.91M(+901.3%)
$965.11M(-74.0%)
Sep 2023
-
$79.59M(-113.0%)
$3.71B(-36.8%)
Jun 2023
-
-$614.24M(-187.4%)
$5.87B(-31.2%)
Mar 2023
-
$702.85M(-80.1%)
$8.53B(-35.2%)
Dec 2022
$15.97B(-23.4%)
$3.54B(+58.2%)
$13.16B(-11.5%)
Sep 2022
-
$2.24B(+9.3%)
$14.86B(-17.4%)
Jun 2022
-
$2.05B(-61.6%)
$18.00B(-14.2%)
Mar 2022
-
$5.33B(+1.7%)
$20.97B(+19.2%)
DateAnnualQuarterlyTTM
Dec 2021
$20.84B(-6958.7%)
$5.24B(-2.5%)
$17.59B(+39.2%)
Sep 2021
-
$5.37B(+7.1%)
$12.64B(+79.4%)
Jun 2021
-
$5.02B(+156.8%)
$7.05B(+263.5%)
Mar 2021
-
$1.95B(+571.1%)
$1.94B(-2482.3%)
Dec 2020
-$303.92M(+47.9%)
$291.16M(-233.6%)
-$81.35M(-81.1%)
Sep 2020
-
-$217.98M(+144.7%)
-$431.12M(+69.6%)
Jun 2020
-
-$89.10M(+36.2%)
-$254.14M(+16.1%)
Mar 2020
-
-$65.44M(+11.7%)
-$218.82M(+7.7%)
Dec 2019
-$205.43M(+197.5%)
-$58.61M(+42.9%)
-$203.17M(+37.9%)
Sep 2019
-
-$41.00M(-23.8%)
-$147.36M(+12.1%)
Jun 2019
-
-$53.77M(+8.0%)
-$131.51M(+69.2%)
Mar 2019
-
-$49.79M(+1683.5%)
-$77.74M(+178.2%)
Dec 2018
-$69.05M(-3.3%)
-$2.79M(-88.9%)
-$27.94M(+11.1%)
Sep 2018
-
-$25.15M
-$25.15M
Dec 2017
-$71.44M
-
-

FAQ

  • What is BioNTech SE annual operating income?
  • What is the all time high annual operating profit for BioNTech SE?
  • What is BioNTech SE annual operating profit year-on-year change?
  • What is BioNTech SE quarterly operating income?
  • What is the all time high quarterly operating profit for BioNTech SE?
  • What is BioNTech SE quarterly operating profit year-on-year change?
  • What is BioNTech SE TTM operating income?
  • What is the all time high TTM operating profit for BioNTech SE?
  • What is BioNTech SE TTM operating profit year-on-year change?

What is BioNTech SE annual operating income?

The current annual operating profit of BNTX is -$695.96M

What is the all time high annual operating profit for BioNTech SE?

BioNTech SE all-time high annual operating income is $20.84B

What is BioNTech SE annual operating profit year-on-year change?

Over the past year, BNTX annual operating income has changed by -$1.68B (-171.08%)

What is BioNTech SE quarterly operating income?

The current quarterly operating profit of BNTX is -$542.60M

What is the all time high quarterly operating profit for BioNTech SE?

BioNTech SE all-time high quarterly operating income is $5.37B

What is BioNTech SE quarterly operating profit year-on-year change?

Over the past year, BNTX quarterly operating income has changed by +$204.13M (+27.34%)

What is BioNTech SE TTM operating income?

The current TTM operating profit of BNTX is -$168.65M

What is the all time high TTM operating profit for BioNTech SE?

BioNTech SE all-time high TTM operating income is $20.97B

What is BioNTech SE TTM operating profit year-on-year change?

Over the past year, BNTX TTM operating income has changed by +$252.49M (+59.95%)
On this page